Attributes | Values |
---|
rdf:type
| |
Description
| - We synthesized novel bioconjugates of cathepsin K inhibitor, 1-(N-benzyl-oxy-carbonylleucyl)-5-(phenylalanylleucyl)-carbo-hydrazide with a-methoxy poly(ethylene glycol), semitelechelic poly[N-(2-hydroxypropyl)-methacrylamide] and HPMA copolymers containing reactive side-chans. The inhibitory activity of macromolecular inhibitors for cysteine proteinases as well as their ability to inhibit cathepsin K activity in synovial fibroblasts were evaluated.
- We synthesized novel bioconjugates of cathepsin K inhibitor, 1-(N-benzyl-oxy-carbonylleucyl)-5-(phenylalanylleucyl)-carbo-hydrazide with a-methoxy poly(ethylene glycol), semitelechelic poly[N-(2-hydroxypropyl)-methacrylamide] and HPMA copolymers containing reactive side-chans. The inhibitory activity of macromolecular inhibitors for cysteine proteinases as well as their ability to inhibit cathepsin K activity in synovial fibroblasts were evaluated. (en)
|
Title
| - Bioconjugates of cathepsin K inhibitors with water/soluble polymers: potential drugs for the treatment of osteoporosis and rheumatoid arthritis.
- Bioconjugates of cathepsin K inhibitors with water/soluble polymers: potential drugs for the treatment of osteoporosis and rheumatoid arthritis. (en)
|
skos:prefLabel
| - Bioconjugates of cathepsin K inhibitors with water/soluble polymers: potential drugs for the treatment of osteoporosis and rheumatoid arthritis.
- Bioconjugates of cathepsin K inhibitors with water/soluble polymers: potential drugs for the treatment of osteoporosis and rheumatoid arthritis. (en)
|
skos:notation
| - RIV/61389013:_____/02:55023337!RIV/2003/AV0/A55003/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(KSK4055109), Z(AV0Z4050913)
|
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61389013:_____/02:55023337
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| |
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...v/mistoKonaniAkce
| |
http://linked.open...i/riv/mistoVydani
| |
http://linked.open...i/riv/nazevZdroje
| - Intelligent Drug Delivery Systems Better and Safer Therapy.
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...ocetUcastnikuAkce
| |
http://linked.open...nichUcastnikuAkce
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| - Kopeček, J.
- Pechar, Michal
- Wang, D.
- Kopečková, P.
- Brömme, D.
|
http://linked.open...vavai/riv/typAkce
| |
http://linked.open.../riv/zahajeniAkce
| |
http://linked.open...n/vavai/riv/zamer
| |
number of pages
| |
http://purl.org/ne...btex#hasPublisher
| - Hacettepe University Pharmacy Faculty
|
https://schema.org/isbn
| |